ARCHIVES

FDA Approves Treatment For Late-Stage Cervical Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014